Spiriva HandiHaler 18 ug/1

Spiriva HandiHaler 18 ug/1 capsules are designed for respiratory use, offering a convenient inhalation method. This medication is commonly associated with maintaining lung function and easing breathing difficulties.

Spiriva HandiHaler 18 ug/1 capsules are typically used for managing chronic obstructive pulmonary disease (COPD) and other respiratory conditions. The primary purpose of this medication is to help improve airflow to the lungs, making it easier to breathe. It is often prescribed for long-term maintenance rather than immediate relief.

Common effects of Spiriva HandiHaler 18 ug/1 capsules may include dry mouth and throat irritation. Some users might experience headaches or dizziness. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Spiriva HandiHaler 18 ug/1 capsules should be handled with care, ensuring proper inhalation technique as instructed. It is important to store the capsules in a cool, dry place and keep them out of reach of children. Always follow the prescribed usage guidelines to minimize potential risks.

Spiriva HandiHaler 18 ug/1 capsules may interact with other medications, particularly those affecting the respiratory system. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions.